Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06880224

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study

Two combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria.

Recruiting

Interested in participating?

Request Info

Key information

Age range

15 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria

Loading trial locations.

About this study

Two combination interventions, each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria:

  • HIV Case Finding Intervention: single arm trial of an HIV case finding and linkage to care intervention targeting young men at risk of HIV infection (n = 6000), particularly young men who have sex with men (YMSM) in Akwa Ibom, Benue, Enugu, Kano, Taraba, and Lagos states who complete HIV testing.

Objectives: To determine the effectiveness of the intervention to:

  • identify youth living with HIV, particularly YMSM and
  • link those who test HIV-positive to HIV care
  • pre-exposure prophylaxis (PrEP) initiation (uptake) among those who test HIV-negative.
  • HIV Treatment Intervention: randomized controlled trial of a medication adherence and viral suppression intervention among youth newly diagnosed with HIV and initiating antiretroviral therapy (ART) for the first time (n = 600) at the participating clinical sites.

Objectives: To determine the effectiveness of the intervention on

  • viral suppression and
  • adherence to ART
  • success of implementation in the target populations

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

HIV Case Finding Intervention:

  • Aged 15 to 24
  • Male birth sex of any current gender identity
  • Understand basic English, Yoruba, Hausa, Igbo or Pidgin English For the PrEP component, must also be HIV-negative

HIV Treatment Intervention:

  • Aged 15 to 24
  • HIV seropositive
  • Initiating ART for the first time at a Clinical Research Performance Site (CRPS) clinic or satellite clinic
  • Understand basic English, Yoruba, Hausa, Igbo or Pidgin English
  • Intention to remain a CRPS patient during follow-up

Exclusion criteria

  • Unable to provide consent
  • No parental permission if aged 15 and not emancipated

Treatment and study plan

Testing Peer navigation

Behavioral

Peer navigators will promote HIV testing in YMSM and linkage to care if HIV-positive

PrEP Intervention

Behavioral

Motivational-interviewing to promote uptake of PrEP among those who test HIV-negative

Treatment Peer Navigation

Behavioral

Peer navigators will provide assistance and support to youth with HIV to optimize adherence to ART

Social Media Outreach

Behavioral

Social media outreach to identify youth at risk for HIV

SMS Test messaging

Behavioral

Text (SMS) messages to remind and encourage youth to adhere to their ART

Adherence standard of care

Other

Standard of care HIV treatment adherence

Primary outcomes

  1. Case Finding: HIV-positive serostatus

    Time frame: 48 weeks

    HIV-positive serostatus based on rapid test with confirmation

  2. Treatment: Viral suppression

    Time frame: 48 Weeks

    Viral suppression (< 200 copies per mL)

Secondary outcomes

  1. Case Finding: Linkage to HIV care

    Time frame: 48 Weeks

    Linkage to HIV care within 30 days of positive HIV test

  2. Case Finding: PrEP among youth who test HIV-negative

    Time frame: 48 weeks

    PrEP uptake among youth who test HIV-negative

  3. Treatment: Adherence to antiretroviral therapy (ART)

    Time frame: 48 Weeks

    > 90% adherence to ART

Study contacts

Contact information is provided by the study sponsor or research team.

Lisa M Kuhns, PhD

CONTACT

[email protected]

312-227-7740

Robert Garofalo, MD

CONTACT

[email protected]

312-227-7740

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Registry information

Official study title

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study: Aim 2

Acronym: iCARE Plus

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Mar 17, 2025
Registry last updated
Apr 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.